Free Trial

Revelation Biosciences (REVBW) Competitors

$0.01 0.00 (-1.54%)
As of 01:46 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

REVBW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Revelation Biosciences stock or one of its competitors? The main competitors of Revelation Biosciences include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Revelation Biosciences vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Revelation Biosciences (NASDAQ:REVBW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

In the previous week, 180 Life Sciences' average media sentiment score of 1.14 beat Revelation Biosciences' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Positive
Revelation Biosciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Revelation BiosciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Revelation Biosciences N/A N/A N/A

Summary

180 Life Sciences beats Revelation Biosciences on 1 of the 1 factors compared between the two stocks.

Get Revelation Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for REVBW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

REVBW vs. The Competition

MetricRevelation BiosciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$137.10M$5.82B$9.71B
Dividend YieldN/A3.74%3.84%4.09%
P/E RatioN/A3.8830.9025.97
Price / SalesN/A4,051.19469.81120.77
Price / CashN/A13.1937.1558.38
Price / BookN/A46.299.116.37
Net IncomeN/A-$90.99M$3.26B$265.56M
7 Day PerformanceN/A0.62%1.85%1.71%
1 Month PerformanceN/A3.44%4.86%1.05%
1 Year PerformanceN/A197.77%31.15%20.94%

Revelation Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
REVBW
Revelation Biosciences
N/A$0.01
-1.5%
N/A-52.1%$0.00N/A0.0010
ATNFW
180 Life Sciences
N/A$0.43
-6.5%
N/A+3,303.8%$0.00N/A0.007Gap Up
High Trading Volume
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
-58.9%
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.47
-31.4%
N/AN/A$0.00$106.21K0.0040Gap Up
ALVOW
Alvotech
N/A$1.15
-11.5%
N/A-62.3%$0.00$585.60M0.004News Coverage
Positive News
Gap Up
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
-31.3%
N/A-47.7%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
-17.8%
N/A+176.9%$0.00$38.00M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.01
+26.9%
N/A-97.4%$0.00$199.07M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.02
flat
N/A-91.4%$0.00N/A0.008Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:REVBW) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners